Without adequate von Willebrand factor, affected dogs may experience spontaneous bleeding or excessive bleeding following even minor injuries, surgeries, or medical procedures.
Among the different forms of von Willebrand Disease, Type 3 is considered the most severe. Dogs affected with vWD3 typically have extremely low or undetectable levels of von Willebrand factor, making them highly vulnerable to serious bleeding episodes. Clinical signs may appear at a young age and can range from mild to life-threatening depending on the severity of bleeding and the situation involved.
Common symptoms of vWD3 include prolonged bleeding from cuts or wounds, nosebleeds, bleeding gums, excessive bruising, blood in the urine or stool, and prolonged bleeding after surgery, vaccination, nail trimming, or tooth eruption. Puppies affected with severe forms may develop spontaneous internal bleeding or severe blood loss after routine procedures. Female dogs may also experience excessive bleeding during heat cycles or after giving birth.
von Willebrand Disease Type 3 is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene — one from each parent — to develop the disease. Dogs carrying only one copy of the mutation are known as carriers. Carrier dogs generally do not show severe symptoms but can pass the defective gene to their offspring. When two carriers are bred together, there is a 25% chance of producing affected puppies, a 50% chance of producing carrier puppies, and a 25% chance of producing genetically clear puppies.
The vWD3 genetic test is designed to identify whether a dog is genetically clear, a carrier, or affected by the mutation associated with the disorder. Testing is simple and typically performed using a cheek swab or blood sample. DNA analysis performed by a specialized laboratory can accurately detect the mutation even before clinical signs develop, allowing breeders and owners to make informed decisions regarding breeding and health management.
Genetic testing plays a critical role in responsible breeding programs. Since affected dogs can suffer serious health complications and carriers may unknowingly spread the mutation, screening breeding dogs helps reduce the risk of producing affected puppies. Avoiding carrier-to-carrier matings is one of the most effective ways to decrease the frequency of the disease within susceptible breeds while preserving overall breed health.
Although there is currently no cure for von Willebrand Disease Type 3, affected dogs can often be managed successfully with proper veterinary care and preventive measures. Treatment focuses on controlling bleeding episodes and minimizing injury risks. In emergency situations or during surgery, blood transfusions, plasma transfusions, or clotting support therapies may be necessary. Veterinarians may also recommend avoiding medications that interfere with blood clotting.
Early diagnosis is extremely important because it allows owners and veterinarians to take precautions before surgeries or other procedures where bleeding risks may be increased. Careful management and regular veterinary monitoring can significantly improve the quality of life for affected dogs.
Testing for von Willebrand Disease Type 3 demonstrates a commitment to responsible breeding and canine health. Identifying affected and carrier dogs helps protect future generations, supports informed breeding choices, and contributes to the long-term welfare and wellbeing of dogs within the breed population.
